NGU Scientists Participated in the Moscow International Veterinary Congress

The XXXIV Moscow International Veterinary Congress (MVC 2026) was held at the Technopark “Skolkovo” from April 8 to 10. This event is the largest industry event in Russia. Its organizer was traditionally the Association of Practicing Veterinarians (RSAVA). This year, more than 5 thousand participants from all over the country gathered at it – from Kaliningrad to Vladivostok, specialists arrived from CIS countries, as well as from China and India. Among the participants were scientists, practicing doctors, and representatives of the veterinary industry.Scientists from the Laboratory of Nuclear and Innovative Medicine of the Physics Faculty of Novosibirsk State University took part in one of the sections of this large-scale event. Within the framework of an extensive scientific program, they presented a report on the application of neutron capture therapy for the treatment of malignant tumors in animals.

The congress program covered all aspects of modern veterinary medicine: from clinic management and rehabilitation to the most complex surgery and oncology. Dozens of sections worked, master classes and symposiums on innovative treatment methods were held. The head of the Laboratory of Nuclear and Innovative Medicine at FF NSUVladimir Kanyginand the leading veterinarian of the “Best” clinicElena Petrovatold about the interdisciplinary project implemented at NGU at the intersection of nuclear physics and medicine “Clinical cases of the use of neutron therapy (NT) in cats and dogs with various malignant tumors.”

—We presented unique results from large-scale studies conducted by us: to date, neutron capture therapy (NCT) has already been performed on 200 animals. In the report, we examined in detail the methodology of conducting the therapy, which was implemented both based on a neutron accelerator source and on a nuclear reactor. Special attention was paid to the innovative approach — the use of compounds not only of boron but also of gadolinium, which significantly expands the therapeutic possibilities of the methods. The main emphasis was placed on real clinical cases.We demonstrated the treatment dynamics of cats and dogs with tumors of various origins: from melanoma and sarcoma to complex carcinoma. A separate section presented the results of brain tumor treatment, in particular those localized in the pituitary gland and hippocampus areas. Statistics and visual materials proved that the technology allows precise destruction of tumor cells while sparing healthy tissues even in cases where surgery or standard radiation therapy are powerless.— toldVladimir Kanygin.

The speech by Vladimir Kanygin and Elena Petrova elicited a lively response from the veterinary community. Immediately after the report, an active discussion began: colleagues asked them many clarifying questions about the protocol for animal preparation, dosage of medications, and long-term prognosis. Vladimir Kanygin noted that such a reaction confirms that the veterinary community is ready to implement high technologies. The representatives of NGU left the congress with the most positive impressions.They noted the high level of audience engagement — veterinarians are ceasing to perceive nuclear medicine as the “technology of the future,” understanding that it is now a reality.

—Participation in the congress became an important step for us: we confirmed that NGU today is a unique and the only platform in the country where veterinarians and their patients can gain access to nuclear medicine of such a level. We have already received a number of partnership proposals from the country’s leading clinics, which will allow us to scale the project,— saidVladimir Kanygin.